Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry
JAMA · 01.08.2023 · 330 (5) · 442
DOI: 10.1001/jama.2023.11676 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA, erschienen am 01.08.2023. Verfasst von William McKleroy und 37 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, School of Medicine, University of California, San Francisco. Hauptthemen laut MEDLINE: Spirometry, Cigarette Smoking, Lung Diseases. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIEHS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Importance People who smoked cigarettes may experience respiratory symptoms without spirometric airflow obstruction. These individuals are typically excluded from chronic obstructive pulmonary disease (COPD) trials and lack evidence-based therapies.
Objective
To define the natural history of persons with tobacco exposure and preserved spirometry (TEPS) and symptoms (symptomatic TEPS). Design, Setting, and Participants SPIROMICS II was an extension of SPIROMICS I, a multicenter study of persons aged 40 to 80 years who smoked cigarettes (>20 pack-years) with or without COPD and controls without tobacco exposure or airflow obstruction. Participants were enrolled in SPIROMICS I and II from November 10, 2010, through July 31, 2015, and followed up through July 31, 2021. Exposures Participants in SPIROMICS I underwent spirometry, 6-minute walk distance testing, assessment of respiratory symptoms, and computed tomography of the chest at yearly visits for 3 to 4 years. Participants in SPIROMICS II had 1 additional in-person visit 5 to 7 years after enrollment in SPIROMICS I. Respiratory symptoms were assessed with the COPD Assessment Test (range, 0 to 40; higher scores indicate more severe symptoms). Participants with symptomatic TEPS had normal spirometry (postbronchodilator ratio of forced expiratory volume in the first second [FEV 1 ] to forced vital capacity >0.70) and COPD Assessment Test scores of 10 or greater. Participants with asymptomatic TEPS had normal spirometry and COPD Assessment Test scores of less than 10. Patient-reported respiratory symptoms and exacerbations were assessed every 4 months via phone calls. Main Outcomes and Measures The primary outcome was assessment for accelerated decline in lung function (FEV 1 ) in participants with symptomatic TEPS vs asymptomatic TEPS. Secondary outcomes included development of COPD defined by spirometry, respiratory symptoms, rates of respiratory exacerbations, and progression of computed tomographic–defined airway wall thickening or emphysema.
Results
Of 1397 study participants, 226 had symptomatic TEPS (mean age, 60.1 [SD, 9.8] years; 134 were women [59%]) and 269 had asymptomatic TEPS (mean age, 63.1 [SD, 9.1] years; 134 were women [50%]). At a median follow-up of 5.76 years, the decline in FEV 1 was −31.3 mL/y for participants with symptomatic TEPS vs −38.8 mL/y for those with asymptomatic TEPS (between-group difference, −7.5 mL/y [95% CI, −16.6 to 1.6 mL/y]). The cumulative incidence of COPD was 33.0% among participants with symptomatic TEPS vs 31.6% among those with asymptomatic TEPS (hazard ratio, 1.05 [95% CI, 0.76 to 1.46]). Participants with symptomatic TEPS had significantly more respiratory exacerbations than those with asymptomatic TEPS (0.23 vs 0.08 exacerbations per person-year, respectively; rate ratio, 2.38 [95% CI, 1.71 to 3.31], P < .001). Conclusions and Relevance Participants with symptomatic TEPS did not have accelerated rates of decline in FEV 1 or increased incidence of COPD vs those with asymptomatic TEPS, but participants with symptomatic TEPS did experience significantly more respiratory exacerbations over a median follow-up of 5.8 years.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care, Sleep, and Allergy, Department of Medicine, School of Medicine, University of California, San Francisco.
- Now with Department of Pulmonary and Critical Care Medicine, Kaiser Permanente San Francisco Medical Center, San Francisco, California.
- Gillings School of Global Public Health, University of North Carolina, Chapel Hill.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, School of Medicine, University of North Carolina, Chapel Hill.
- Division of Pulmonary and Critical Care Medicine, Medical Service, San Francisco VA Medical Center, San Francisco, California.
- Roy J. Carver Department of Biomedical Engineering, University of Iowa, Iowa City.
Förderung
- NHLBI NIH HHS
- NIEHS NIH HHS
- NCI NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
Zitieren
APA
McKleroy, W., Shing, T., Anderson, W. H., Arjomandi, M., Awan, H. A., Barjaktarevic, I., Barr, R. G., Bleecker, E. R., Boscardin, J., Bowler, R. P., Buhr, R. G., Criner, G. J., Comellas, A. P., Curtis, J. L., Dransfield, M., Doerschuk, C. M., Dolezal, B. A., Drummond, M. B., Han, M. K., …, & Woodruff, P. G. (2023). Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry. JAMA, 330(5), 442. https://doi.org/10.1001/jama.2023.11676
Vancouver
McKleroy W, Shing T, Anderson WH, Arjomandi M, Awan HA, Barjaktarevic I, et al. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry. JAMA. 2023;330(5):442. doi:10.1001/jama.2023.11676
BibTeX
@article{McKleroy2023,
author = {McKleroy, William and Shing, Tracie and Anderson, Wayne H and Arjomandi, Mehrdad and Awan, Hira Anees and Barjaktarevic, Igor and Barr, R Graham and Bleecker, Eugene R and Boscardin, John and Bowler, Russell P and Buhr, Russell G and Criner, Gerard J and Comellas, Alejandro P and Curtis, Jeffrey L and Dransfield, Mark and Doerschuk, Claire M and Dolezal, Brett A and Drummond, M Bradley and Han, MeiLan K and Hansel, Nadia N and Helton, Kinsey and Hoffman, Eric A and Kaner, Robert J and Kanner, Richard E and Krishnan, Jerry A and Lazarus, Stephen C and Martinez, Fernando J and Ohar, Jill and Ortega, Victor E and Paine, Robert and Peters, Stephen P and Reinhardt, Joseph M and Rennard, Stephen and Smith, Benjamin M and Tashkin, Donald P and Couper, David and Cooper, Christopher B and Woodruff, Prescott G},
title = {Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry},
journal = {JAMA},
year = {2023},
volume = {330},
number = {5},
pages = {442},
doi = {10.1001/jama.2023.11676}
}
EUVIMED